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There are an estimated 1.1 million people in the United States 
living with human immunodeficiency virus (HIV) and its dis-
ease progression, acquired immunodeficiency syndrome (AIDS). 
Despite prevention efforts, an estimated 56,300 new individuals 
were infected with HIV in the United States in 2006, the most 
recent year for which data are available.1 Nearly 30 years after the 
identification of the disease, there is no approved vaccine or cure 
for HIV/AIDS but it can be treated with highly active anti-retro-
viral therapy (HAART), which slows the progression of HIV to 
AIDS. For those with access to it through private or public health 
insurance or other programs, HAART can transform the effects 
of the virus so that the illness becomes a chronic condition, rather 
than a terminal one. 
HIV/AIDS disproportionately impacts certain populations, cre-
ating alarming levels of death and disability. African American 
males have the highest rates of HIV infection. In 2006, the HIV 
diagnosis rate for all African American males was more than sev-
en times that for White males, more than twice the rate for His-
panic males, and more than twice the rate for African American 
females. HIV infection rates among African American females 
are disproportionately high. In 2006, the HIV diagnosis rate for 
African American females was more than 19 times the rate for 
White females. In 2006, HIV disease was the sixth leading cause 
of death among persons 24 through 44 years old, after uninten-
tional injury, cancer, heart disease, suicide, and homicide. It was 
the fourth leading cause of death for African American males 
and females aged 25 through 34, and the fourth leading cause of 
death among Hispanic males and females aged 35 through 44.2 
The largest transmission category for people living with HIV/
AIDS consists of men who have sex with men.3 
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Medicaid and the Ryan White HIV/AIDS Program are the two 
key federal programs that fund treatment for low-income, unin-
sured, and underinsured people living with HIV/AIDS.4 The 
Ryan White Program provides funding to metropolitan areas, 
states, and community-based organizations through awards and 
grants; it is not health insurance. Ryan White funds pay for core 
medical services, defined as outpatient and ambulatory medical 
services, medications, mental health and substance abuse ser-
vices, oral health care, hospice care, early intervention services, 
health insurance premium and cost sharing assistance, medical 
nutrition therapy, home health care, and support services such as 
transportation, respite care, outreach, and language services. 
Unlike Ryan White, Medicaid is health insurance and provides 
a broader array of medical services including inpatient care and 
long-term care services. There is limited eligibility for Medicaid 
for persons living with HIV that has not progressed to AIDS. 
Often the only avenue of eligibility, no matter how poor a person 
may be, is through a total disability determination by the Social 
Security Administration and therefore eligibility for Supplemen-
tal Security Income (SSI), which in some states automatically 
qualifies a person for Medicaid. 
As a discretionary program—not an entitlement like Medicaid—
Ryan White funds are finite, so services are provided while funds 
last. Ryan White funds serve an estimated 529,000 people per year, 
the majority of whom live below the federal poverty line and are 
ethnic and racial minorities.
The Ryan White HIV/AIDS Program is authorized as Title XXVI 
of the Public Health Service Act. Congress created it in 1990 and 
reauthorized the program in 1996, 2000, 2006, and 2009. The most 
recent reauthorization, the Ryan White HIV/AIDS Treatment 
Extension Act of 2009 (Public Law 111-87), extended the program 
for four years, through September 30, 2013. The authorizing com-
mittees of jurisdiction are the Senate Committee on Health, Edu-
cation, Labor, and Pensions and the House of Representatives 
Committee on Energy and Commerce. Congress appropriated 
$2.3 billion for Ryan White in fiscal year (FY) 2010; the Health 
Resources and Services Administration (HRSA) within the 
Department of Health and Human Services (DHHS) administers 
the program.
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RYAN WHITE PROGRAM COMPONENTS
Par t A 
Part A of the Ryan White HIV/AIDS Program awards funds to 
eligible metropolitan areas (EMAs), defined as areas that have a 
population of at least 50,000 and a cumulative total of more than 
2,000 reported AIDS cases within the past five years, and to tran-
sitional grant areas (TGAs), defined as areas with a population of 
at least 50,000 with a cumulative total of 1,000 to 1,999 reported 
AIDS cases within the past five years.5 
Two-thirds of Part A funds are distributed through formula 
awards and the remaining third through competitive supplemen-
tal grants on the basis of the severity of need. Funds are directed to 
the chief elected official (CEO) of the EMA. The CEO is required 
to appoint a local planning council that has broad representation 
and has responsibility for assessing needs, setting service priori-
ties, and directing the CEO to purchase medical and support ser-
vices to meet the needs of the local population living with HIV/
AIDS. While TGAs are not required to have planning councils, 
they are required to utilize a community planning process in 
determining how these funds should be used. 
Until the 2006 reauthorization, Ryan White formula funds were 
distributed on the basis of AIDS case data. Case data is collected 
through surveillance systems that were historically either code-
based or name-based surveillance systems. Name-based HIV 
reporting has been recommended by the Centers for Disease Con-
trol and Prevention (CDC) since 2005 for all states and territories 
to avoid double counting of cases, but some states kept code-based 
systems because of concerns about client confidentiality. The 2006 
reauthorization made two significant changes related to case data: 
it mandated the distribution of funds based on HIV and AIDS 
data in an effort to target funding to the epidemic of HIV cases 
before they progress to AIDS, and it mandated a time table for 
states to transition to name-based HIV surveillance systems. Cur-
rently all states have name-based HIV surveillance systems in 
place, but some are still maturing. Recognizing this, the 2009 reau-
thorization continues funding through FY 2012 to those jurisdic-
tions with reporting systems that are not yet mature. For funding 
purposes, the HIV case counts from states with immature systems 
will be reduced by 5 percent for FYs 2010 and 2011 and 6 percent 
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for 2012. In addition, grant amounts for successive years are lim-
ited to no more than a 5 percent increase over the previous year. 
Only name-based case data will be accepted beginning in FY 2013. 
With the move to funding that is based on HIV and AIDS cas-
es in 2006, there was concern that a number of states and locali-
ties would experience significant funding shifts that would dis-
rupt care for people living with HIV/AIDS. To ameliorate these 
shifts, the 2006 reauthorization created hold harmless provisions 
to ensure that an EMA does not receive a formula award that is 
less than a specified percentage of what it received in the base 
year. The 2009 reauthorization retains hold harmless provisions, 
ensuring that in FY 2010 EMAs will receive 95 percent of the sum 
of the FY 2009 formula award and FY 2009 hold harmless amount 
and, for FYs 2011 and 2012, 100 percent of the sum of the FY 2010 
formula award and FY 2010 hold harmless amount. For FY 2013, 
EMAs will receive 92.5 percent of the sum of the FY 2012 formula 
award and the FY 2012 hold harmless amount. Hold harmless pro-
visions are funded through the one-third of Part A funds that are 
set aside for supplemental grants. 
Though not a part of the program’s authorization, stop loss provi-
sions in appropriations bills for fiscal years 2008, 2009, and 2010 
have affected the distribution of Part A funds. In general, the 
provisions set aside Part A funds to make up for losses to certain 
areas that resulted from the implementation of provisions of the 
2006 reauthorization.6
Par t B 
Part B consists of four components—base, supplemental, base 
AIDS Drug Assistance Program (ADAP), and supplemental 
ADAP—which are designed to allocate resources on the basis of 
relative need.7 
The Part B base award formula provides funds to states and the 
District of Columbia, Puerto Rico, the U.S. Virgin Islands, the 
Republic of the Marshall Islands, Guam, American Samoa, the 
Commonwealth of the Northern Mariana Islands, the Federated 
States of Micronesia, and the Republic of Palau. The formula con-
sists of three components: 75 percent is based on the state’s pro-
portion of total HIV/AIDS cases compared with the total U.S. HIV/
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AIDS cases, 20 percent is based on the state’s proportion of HIV/
AIDS cases outside EMAs and TGAs, and 5 percent is based on 
the state’s proportion of HIV/AIDS cases in states with no Part A 
funding. At least 75 percent of funds must be spent on core medi-
cal services, and up to 25 percent may be spent on support services. 
A competitive supplemental grant program exists for those states 
with a demonstrated need for additional assistance.
About one-quarter of total Ryan White funding—$835 million in 
FY 2010—is earmarked by Congress for AIDS Drug Assistance Pro-
grams (ADAPs). States receive ADAP funds on the basis of their 
proportion of living HIV/AIDS cases compared with the total 
number of cases in the United States. In addition to the federal 
grant, many ADAPs receive state general revenue funding and 
funds from rebates negotiated with drug manufacturers. 
ADAPs operate in all jurisdictions that receive base formula 
awards, except the Republic of Palau. To receive services from an 
ADAP, jurisdictions must ensure 
that an individual has been diag-
nosed with HIV and that he or 
she qualifies as “low income,” as 
defined by the jurisdiction. Grant-
ees primarily provide prescription 
drugs approved by the Food and 
Drug Administration to eligible 
individuals, but they may also use 
funds to purchase health insur-
ance for eligible clients if that cov-
erage includes a prescription drug 
benefit equal to or greater than 
that of the state-run ADAP, and 
for services that enhance access 
to, adherence to, and monitoring 
of drug treatments. Five percent 
of the ADAP appropriation is set 
aside for competitive supplemental 
ADAP grants for those jurisdictions 
with a severe need to increase 
availability of HIV/AIDS drugs. 
The 2009 reauthorization hold 
harmless provision that created a 
RYAN WHITE FUNDING BY PART, FISCAL YEAR 2010
PART* FUNDING TYPES APPROPRIATION 
A
Formula awards to eligible metropolitan areas 
and transitional grant areas; competitive supple-
mental grants
$679.1 million
B
Formula base awards; competitive supplemental 
grants; emerging communities awards
$418.8 million
AIDS Drug Assistance Program (ADAP) base 
awards; ADAP competitive supplemental grants
$835.0 million
C
Competitive grants for early intervention ser-
vices, planning, and capacity development 
$206.8 million
D
Competitive grants for programs serving 
women, infants, children, and youth
$77.8 million
F 
AIDS Education and Training Centers $34.8 million
Dental Programs $13.6 million
TOTAL $2.3 billion
*  No funds have been appropriated for Part E.
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transition period for states with immature name-based HIV sur-
veillance systems (as described under Part A) applies to Part B 
grants as well. In FY 2010, Part B grantees will receive 95 percent of 
the FY 2009 formula and ADAP award; for FYs 2011 and 2012, 100 
percent of the FY 2010 formula and ADAP award; and for FY 2013, 
92.5 percent of the FY 2012 formula and ADAP award. Hold harm-
less provisions are funded out of the one-third of Part B funds 
(non-ADAP) set aside for supplemental grants and any unobligated 
funds repaid by the states.
In addition to the four components, Part B also awards emerg-
ing community grants for the provision of HIV-related services in 
those metropolitan areas with 500 to 1,000 reported AIDS cases 
over the last five years. Funds are distributed based on the num-
ber of the emerging community’s living HIV/AIDS cases relative 
to all living HIV/AIDS cases in emerging communities nationwide. 
PART C
Whereas the first two parts of the Program fund metropolitan 
areas and states mainly through formula awards, Part C provides 
funds to community-based organizations through a competitive 
grant application process. Eligible organizations include public 
and private nonprofit organizations; primary care providers such 
as federally qualified health centers, local health departments, 
hemophilia treatment centers, rural health clinics, Indian Health 
Service facilities; and outpatient facilities at academic medical 
centers that serve people living with HIV/AIDS. The 2006 law 
stipulated that at least 75 percent of funds must be used to pro-
vide core medical services, and at least half of those services must 
be early intervention services. Early intervention services include 
counseling, HIV testing, referrals, and other clinical and diag-
nostic services related to HIV/AIDS.8 
PART D 
Part D provides funds for family-centered care for women, infants, 
children, and youth with HIV/AIDS. Grants are awarded com-
petitively to public and private nonprofit organizations to pro-
vide outpatient or ambulatory care, case management, referrals 
for inpatient care, substance abuse and mental health services, 
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support services, outreach, and access to clinical trials and clini-
cal research. A special focus of Part D is to identify HIV-positive 
pregnant women and ensure that they have access to prenatal 
care to prevent mother-to-child transmission of the virus. There 
is no statutory set-aside of funds for core medical services in Part 
D; Part D program funds are not required to be used for primary 
care services if those services are paid for by other sources like 
Medicaid or the Children’s Health Insurance Program.9 
PART E 
Part E includes a number of provisions about coordination of fed-
eral HIV programs, audits of grantees, definitions, and prohibi-
tions on use of funds. No funds have been appropriated for Part E.
PART F 
Part F includes the AIDS Education and Training Centers (AETC) 
Program, two dental programs, and the Special Projects of 
National Significance Program, all of which are competitively 
awarded. AETC is the clinical training component of the Act that 
provides funding for national and regional centers that conduct 
multidisciplinary training and education programs for health 
care providers who treat patients with HIV/AIDS. The Ryan White 
Dental Reimbursement Program reimburses dental schools, post-
doctoral dental programs, and dental hygiene programs for the 
uncompensated services they provide to people living with HIV/
AIDS. The Community-Based Dental Partnership Program works to 
increase access to oral health care services for people living with 
HIV while providing education and clinical training for dental 
care providers, especially those in community-based settings. 
The Special Projects of National Significance Program is designed 
to address the emerging needs of Ryan White clients and to assist 
in the development of a standard electronic client information 
data system to improve grantee reporting of client-level data. The 
Minority AIDS Initiative (MAI) addresses the disproportionate 
impact of HIV/AIDS on racial and ethnic minorities. MAI funding 
is woven throughout the various Parts of the program. The 2006 
reauthorization shifted the funding from formula-based to com-
petitive for Parts A and B. The 2009 reauthorization reverted the 
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competitive MAI funding to formula funding based on the dis-
tribution of HIV/AIDS cases among racial and ethnic minorities.10
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